Al Khaldi, M.; Fellouah, M.; Drolet, P.; Côté, J.; Trilling, B.; Brind’Amour, A.; Dugas, A.; Tremblay, J.-F.; Fortin, S.; De Guerké, L.;
et al. The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Curr. Oncol. 2022, 29, 9314-9324.
https://doi.org/10.3390/curroncol29120730
AMA Style
Al Khaldi M, Fellouah M, Drolet P, Côté J, Trilling B, Brind’Amour A, Dugas A, Tremblay J-F, Fortin S, De Guerké L,
et al. The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Current Oncology. 2022; 29(12):9314-9324.
https://doi.org/10.3390/curroncol29120730
Chicago/Turabian Style
Al Khaldi, Maher, Massine Fellouah, Pierre Drolet, Julien Côté, Bertrand Trilling, Alexandre Brind’Amour, Alexandre Dugas, Jean-François Tremblay, Suzanne Fortin, Lara De Guerké,
and et al. 2022. "The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy" Current Oncology 29, no. 12: 9314-9324.
https://doi.org/10.3390/curroncol29120730
APA Style
Al Khaldi, M., Fellouah, M., Drolet, P., Côté, J., Trilling, B., Brind’Amour, A., Dugas, A., Tremblay, J.-F., Fortin, S., De Guerké, L., Auclair, M.-H., Dubé, P., Soucisse, M., & Sideris, L.
(2022). The Impact of Computed Tomography Measurements of Sarcopenia on Postoperative and Oncologic Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Current Oncology, 29(12), 9314-9324.
https://doi.org/10.3390/curroncol29120730
